NVS eschewed the apparently mandated 'patent dance' for biosimilars and lost in both lower courts as a result. This case overturns those rulings and says NVS followed the correct approach after all. See Message 111544783 for background.
“It is possible to be a normal decent person and yet to be fully alive.” - George Orwell